References
- 1. Smith HS. Variations in opioid responsiveness. Pain Physician. 2008 Mar-Apr; 11(2): 237–48.
- 2. Somogyi AA, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin Pharmacol Ther. 2007 Mar; 81(3): 429–44.
- 3. Jones AK, Watabe H, Cunningham VJ, Jones T. Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C] diprenorphine binding and PET. Eur J Pain. 2004 Oct; 8(5): 479–85.
- 4. Maarrawi J, Peyron R, Mertens P, Costes N, Magnin M, Sindou M, Laurent B, Garcia-Larrea L Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain. 2007 Jan; 127(1–2): 183–94.
- 5. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 2006; 234: 4–33. 51.
- 6. Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 2006; 112: 457–473. 52.
- 7. Ameyaw MM, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N, Folayan GO, Githang’s J, Indalo A, Ofori-Adjei D, Price-Evans DA, McLeod HL. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001; 11: 217–221. 53.
- 8. Skarke C, Jarrar M, Schmidt H, Kauert G, Langer M, Geisslinger G, Lötsch J. Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers. Pharmacogenetics 2003; 13: 651–66.
- 9. Rhodin A, Grönbladh A, Ginya H, Nilsson KW, Rosenblad A, Zhou Q, et al. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
Mol Brain. 2013 Feb 12;6:8. doi: 10.1186/1756-6606-6-8. - 10. Zhang W, Yuan JJ, Kan QC, Zhang LR, Chang YZ, Wang ZY. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting inducedby fentanyl intravenous analgesia. Minerva Anestesiol. 2011 Jan; 77(1): 33–9.
- 11. Zhang W, Chang YZ, Kan QC, Zhang LR, Lu H, Chu QJ, et al. Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients.
Anaesthesia. 2010 Feb; 65(2): 130–5. - 12. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R, et al. A118G Single Nucleotide Polymorphism of Human-Opioid Receptor Gene Influences Pain Perception and Patient-controlled Intravenous Morphine Consumption after Intrathecal Morphine for Postcesarean Analgesia. Anesthesiology 2008; 109: 520–6.
- 13. Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 2006; 50: 787–792.
- 14. Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 2001; 90: 261–9.
- 15. Cepeda MS, Carr DB. Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesthesia and Analgesia 2003; 97: 1464–8.
- 16. Bastami S, Gupta A, Zackrisson AL, Ahlner J, Osman A, Uppugunduri S. Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption. Basic Clin Pharmacol Toxicol. 2014 Nov; 115(5): 423–31.
- 17. Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M, et al. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol. 2002 Dec; 54(6): 592–60.
- 18. Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Trégouet D, et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther. 2006 Apr; 79(4): 316–24.
- 19. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene. 2003 Oct 20; 22(47): 7468–85.
- 20. Gong XD, Wang JY, Liu F, Yuan HH, Zhang WY, Guo YH, Jiang B. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev. 2013; 14(5): 2937–43.
- 21. Candiotti K, Yang Z, Xue L, Zhang Y, Rodriguez Y, Wang L, et al. Single-nucleotide polymerphism C3435T in the ABCB1 gene is associated with opioid consumption in postoperative pain. Pain Med. 2013 Dec; 14(12): 1977–84.
- 22. Walldén J, Lindberg G, Sandin M, Thörn SE, Wattwil M. Effects of fentanyl on gastric myoelectrical activity: a possible association with polymorphisms of the mu-opioid receptor gene? Acta Anaesthesiol Scand. 2008 May; 52(5): 708–15.
- 23. Gong XD, Wang JY, Liu F, Yuan HH, Zhang WY, Guo YH, Jiang B. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev. 2013; 14(5): 2937–43.